Therapy News and Research

RSS

FDA approves HEMLIBRA for treatment of hemophilia A

Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.

5 Oct 2018

New approach could lead to precise treatments for traumatic brain injury

Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

5 Oct 2018

Depressed women with sexual abuse histories benefit from Interpersonal Psychotherapy-Trauma

Women sexually abused in childhood and adolescence who suffer from depression and post-traumatic stress disorder benefit significantly from Interpersonal Psychotherapy-Trauma, according to a Rutgers researcher.

4 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.

4 Oct 2018

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

This was the ethical dilemma faced by doctors at Wits Donald Gordon Medical Centre to save a child's life.

4 Oct 2018

Working with Next Health World Innovation Forum to build a healthier future

The Innovation Forum is partnering with the Milner Therapeutics Institute in 2019 for the Next Health World Innovation Forum – a new international healthcare conference taking place from 26-27 June 2019, in Cambridge, UK.

4 Oct 2018

Discovery opens door to new therapies for type 1 diabetes

Researchers at St Vincent’s Institute in Melbourne have identified a key target of the immune response that causes type 1 diabetes.

4 Oct 2018

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

The married professors were spending their Thanksgiving holiday in Egypt when the husband, Thomas L. Patterson, Ph.D., got very sick very quickly, experiencing fever, nausea and a racing heartbeat. By the time Patterson was accurately diagnosed with a highly multi-drug resistant bacterial infection, he was near death.

4 Oct 2018

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research group led by Nuno Barbosa Morais, Group Leader at Instituto de Medicina Molecular João Lobo Antunes, and now published open access in Nucleic Acids Research.

4 Oct 2018

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.

4 Oct 2018

Study: Reducing mutated Huntington disease protein restores psychiatric impairments in mice

New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.

4 Oct 2018

Stevens researchers develop new class of molecules for breast cancer treatment

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

4 Oct 2018

Physical therapy can effectively treat infants with congenital muscular torticollis

Congenital muscular torticollis is a common postural deformity in infants, and one that can be effectively treated by physical therapy.

3 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

Eagle Pharmaceuticals, Inc. today announced that it has entered into an agreement with the United States Army Medical Research Institute of Chemical Defense, the nation's leading science and technology laboratory in the area of medical chemical countermeasures research and development, to conduct a study to evaluate the neuroprotective effects of RYANODEX.

3 Oct 2018

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

Therapure Biomanufacturing, an integrated contract development and manufacturing organization and a division of Therapure Biopharma Inc., today announced approval for the manufacturing of Insmed Incorporated's ARIKAYCE® at its Mississauga facility by the U.S. Food and Drug Administration.

3 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

ATS releases new guideline to help clinicians manage malignant pleural effusions

A new guideline to help clinicians manage malignant pleural effusions has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology.

3 Oct 2018

Therapy News and Research

FDA approves HEMLIBRA for treatment of hemophilia A

New approach could lead to precise treatments for traumatic brain injury

Depressed women with sexual abuse histories benefit from Interpersonal Psychotherapy-Trauma

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

Working with Next Health World Innovation Forum to build a healthier future

Discovery opens door to new therapies for type 1 diabetes

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

Study: Reducing mutated Huntington disease protein restores psychiatric impairments in mice

Stevens researchers develop new class of molecules for breast cancer treatment

Physical therapy can effectively treat infants with congenital muscular torticollis

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

ATS releases new guideline to help clinicians manage malignant pleural effusions

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News